Therapeutic potential of GP IIb/IIIa receptor antagonists in acute myocardial infarction

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.11, 2001-11, pp. : 1965-1976

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GP IIb/IIIa receptor antagonists beneficial in acute coronary syndromes

Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Acute Ischaemic Stroke: Scientific Rationale and Available Evidence

By Arthur M. Pancioli

CNS Drugs, Vol. 18, Iss. 14, 2004-01 ,pp. : 981-988

Adis International

Access to resources Recommend Favorite

Optimizing Reperfusion Therapy: Adjunct Use of Glycoprotein IIb/IIIa Antagonists with Fibrinolytic Therapy in Acute Myocardial Infarction

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 52-55

Karger

Access to resources Recommend Favorite

Enoxaparin sodium and GP IIb/IIIa receptor antagonists: NICE findings

Inpharma, Vol. 1, Iss. 1256, 2000-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

UK NICE guidance on GP IIb/IIIa receptor antagonists released

Inpharma, Vol. 1, Iss. 1258, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite